Navigation Links
MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
Date:12/19/2012

GPO (group purchasing organization) sales channel in the U.S. Given that a majority of hospitals in the U.S. are members of a GPO, this distribution channel has the ability to effectively showcase our products on a much wider scale than we could ever do in-house. These types of efficiencies permit us to focus our resources on reengineering and refreshing our existing products and developing new products to drive future growth.

"In the just concluded fiscal year," continued Dr. Lehman, "we initiated the roll-out of our new Real Time Diffusion product, which has been very well received to this point and that we expect will generate substantial traction in fiscal 2013. We expect to introduce two new products in fiscal 2013 that will be important contributors to the top and bottom lines in the coming years. New product development is a priority at MGC Diagnostics and we are uniquely positioned to bring innovation to a space that has traditionally relied on older technology. We are focusing on improving operating efficiencies, achieving better patient outcomes and managing costs in a manner consistent with the needs of the market and the coming regulatory requirements."

Dr. Lehman concluded, "With the Company appropriately reconfigured, we are now at the proverbial starting line as a company that is right-sized, with a highly-focused management team, a commitment to new product development, and a motivated sales force with the necessary tools to take this company to the next level of its development in the coming years. There are great opportunities ahead and we look forward to fully developing those opportunities to drive value for our customers, employees and our loyal shareholders."

Discontinued Operations In reporting these results for the three months and the fiscal years ended October 31, 2012 and 2011, the Company is presenting results from its New Leaf business line as "discontinued operations." In December 2011, the Company announced that i
'/>"/>

SOURCE MGC Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
(Date:8/26/2014)... , Aug. 26, 2014  Ruthigen Inc. (NASDAQ: ... on improving patient outcomes and reducing healthcare costs ... drug candidate, RUT58-60, has received a recommendation from ... patients in the Company,s planned Phase 1/2 clinical ... as an adjunct therapy in combination with prophylactic ...
(Date:8/26/2014)...   Organovo Holdings, Inc. (NYSE MKT: ONVO) ... 3D bioprinting technology, announced today that it has been recognized ... World Economic Forum (WEF) .  Organovo is one ... creativity to design and create transformative solutions. ... Pioneer by the World Economic Forum for the innovation ...
Breaking Medicine Technology:Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 2Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 4Organovo Named 2015 Technology Pioneer by World Economic Forum 2Organovo Named 2015 Technology Pioneer by World Economic Forum 3
... Primary Endpoint, with Positive Effect Sustained Through ... Duration of 4-Week ... VNDA ) (Vanda) today announced positive top-line results from,a Phase III ... agonist, met the primary endpoint,of the trial and significantly improved sleep ...
... with initiatives aimed at knowledge transfer, including landmark ... Massachusetts and the Italian government in ... an innovator and,leader in global patient recruitment for clinical ... of initiatives to make its,quarter-century of expertise more accessible ...
Cached Medicine Technology:Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 2Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 3Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 4Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 5Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 6Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 7Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 8Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 9BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 4
(Date:8/27/2014)... Georgia (PRWEB) August 27, 2014 ... of PartnerTech AB, a major systems integration and ... Impact Cryotherapy offering the first U.S. designed ... Inc. offered the ideal combination of manufacturing expertise, ... cryotherapy system. Impact Cryotherapy, headquartered in Atlanta, GA, ...
(Date:8/26/2014)... Hearing aids are not always ... plan holders to determine what their hearing care benefits are. ... additional health plans and has published benefit details on their ... , The following is a list of insurances or ... , NYSHIP/ NYS Empire Plan - Hearing Aid Benefit is ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Leelanau ... a fabulous time to visit the region’s wineries. Rolling ... backdrop to wine tasting fun in a weekend event ... Kicking off the festivities is an optional race through ... Vineyards in Suttons Bay. A unique course between rows ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 The ... recipients of the Bruce Simpson Winemaker Scholarship. The ... recipients will each receive $1,000 for the 2014/2015 ... Stemo, Alexis Bogdanova-Hanna and Ashley Nitz. , The ... careers as winemakers and vineyardists in northern Michigan. ...
(Date:8/26/2014)... Charles, LA (PRWEB) August 27, 2014 ... irreversible, it simply makes sense to use hearing ... risk losing hearing forever. There are many different ... and recreational use. Employers generally provide hearing protection ... law enforcement, and other noisy industries. The National ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 3Health News:The Leelanau Peninsula Vintners Association (LPVA) Awards Its First-ever Bruce Simpson Winemakers Scholarships 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 3
... N.C. The addition of a chemotherapeutic drug for leukemia ... to enhance the response of certain ovarian cancers to treatment, ... Duke Comprehensive Cancer Center. , "We know that a ... types of cancers, including some ovarian cancers," said Deanna Teoh, ...
... 18 "Getting closer to controlling cancer" requires funding ... of the new federal stimulus, say former White House ... Washington University Medical Center breast cancer laboratory director, ... Denver Post. Weiner, Berg, and former government analyst Paulette ...
... Awareness Month , , SATURDAY, April 18 (HealthDay News) -- ... 200 sites across the United States in May, which ... and children with symptoms such as wheezing, coughing and ... the screenings that will be conducted by allergists. , ...
... (Nasdaq: ISTA ), today announced it will release first ... a conference call to discuss these results and provide a pipeline ... Date: Thursday, May 7, 2009, Time: 5:00 ... Internet: www.istavision.com, Domestic dial-in: 866-356-3377, ...
... PTU can cause liver disease, experts say , , FRIDAY, April ... of the antithyroid drug (PTU) in children has been endorsed ... editor in the April 9 New England Journal of ... liver disease in children and should no longer be used ...
... Perspective HARRISBURG, Pa., April 17 Agriculture ... the first meeting of the Governor,s Food Safety Council on ... The council will meet from 1 p.m. to 4 p.m. ... Harrisburg Area Community College . The council will hear a ...
Cached Medicine News:Health News:Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers 2Health News:Getting Closer to Controlling Cancer Requires Funding More Laboratories and Commitment Beyond Two Years of New Stimulus, Weiner and Berg Assert in Denver Post Oped 2Health News:Group Urges Public to Take Free Asthma Tests in May 2Health News:Drug May Be Dangerous for Kids With Graves' Disease 2Health News:Pennsylvania Governor's Food Safety Council to Hold First Meeting on April 22 2
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: